[HTML][HTML] A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos

S Rankin-Turner, P Vader, L O'Driscoll, B Giebel… - Advanced drug delivery …, 2021 - Elsevier
Extracellular vesicles (EVs) are complex nanoparticles required for the intercellular transfer
of diverse biological cargoes. Unlike synthetic nanoparticles, EVs may provide a natural …

Overview and update on methods for cargo loading into extracellular vesicles

Y Han, TW Jones, S Dutta, Y Zhu, X Wang… - Processes, 2021 - mdpi.com
The enormous library of pharmaceutical compounds presents endless research avenues.
However, several factors limit the therapeutic potential of these drugs, such as drug …

M2 Macrophagy-derived exosomal miRNA-5106 induces bone mesenchymal stem cells towards osteoblastic fate by targeting salt-inducible kinase 2 and 3

Y Xiong, L Chen, C Yan, W Zhou, T Yu, Y Sun… - Journal of …, 2020 - Springer
Background Osteoblast differentiation is a vital process for fracture healing, and exosomes
are nanosized membrane vesicles that can deliver therapeutic drugs easily and safely …

Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases

AN Saiyed, AR Vasavada, SRK Johar - Future Journal of Pharmaceutical …, 2022 - Springer
Background Researchers now have a new avenue to investigate when it comes to miRNA-
based therapeutics. miRNAs have the potential to be valuable biomarkers for disease …

Extracellular vesicle nanoarchitectonics for novel drug delivery applications

S Sharma, MK Masud, YV Kaneti, P Rewatkar… - Small, 2021 - Wiley Online Library
Extracellular vesicles (EVs) can transfer intercellular messages in various (patho)
physiological processes and transport biomolecules to recipient cells. EVs possess the …

[HTML][HTML] Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model

Z Li, P Zhao, Y Zhang, J Wang, C Wang, Y Liu… - Theranostics, 2021 - ncbi.nlm.nih.gov
Familial hypercholesterolemia (FH), with high LDL (low-density lipoprotein) cholesterol
levels, is due to inherited mutations in genes, such as low-density lipoprotein receptor …

Extracellular vesicles and immunity: at the crossroads of cell communication

N Aloi, G Drago, S Ruggieri, F Cibella… - International journal of …, 2024 - mdpi.com
Extracellular vesicles (EVs), comprising exosomes and microvesicles, are small
membranous structures secreted by nearly all cell types. They have emerged as crucial …

Exosomes as carriers for drug delivery in cancer therapy

W Zeng, Z Wen, H Chen, Y Duan - Pharmaceutical Research, 2023 - Springer
Exosomes are extracellular vesicles secreted by cells with a particle size of 30–150 nm in
diameter. Exosomes can be used as natural drug carriers. The treatment of cancer with drug …

[HTML][HTML] Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment

Z Yang, P Ji, Z Li, R Zhang, M Wei, Y Yang, L Yuan… - Theranostics, 2023 - ncbi.nlm.nih.gov
Extracellular vesicle (EV)-based low-density lipoprotein receptor (Ldlr) mRNA delivery
showed excellent therapeutic effects in treating familial hypercholesterolemia (FH) …

Extracellular vesicles for therapeutic nucleic acid delivery: loading strategies and challenges

A Oshchepkova, M Zenkova, V Vlassov - International Journal of …, 2023 - mdpi.com
Extracellular vesicles (EVs) are membrane vesicles released into the extracellular milieu by
cells of various origins. They contain different biological cargoes, protecting them from …